pd 173074 has been researched along with Liver Neoplasms in 3 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cholangiocarcinoma is an intractable cancer, with limited therapeutic options, in which the molecular mechanisms underlying tumor development remain poorly understood." | 1.40 | Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. ( Arai, Y; Furuta, K; Hama, N; Hosoda, F; Kosuge, T; Nakamura, H; Ojima, H; Okusaka, T; Shibata, T; Shimada, K; Shirota, T; Totoki, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, C | 1 |
| Qian, H | 1 |
| Wang, J | 1 |
| Zhao, T | 1 |
| Ma, P | 1 |
| Wang, S | 1 |
| Zhang, T | 1 |
| Liu, X | 1 |
| Arai, Y | 1 |
| Totoki, Y | 1 |
| Hosoda, F | 1 |
| Shirota, T | 1 |
| Hama, N | 1 |
| Nakamura, H | 1 |
| Ojima, H | 1 |
| Furuta, K | 1 |
| Shimada, K | 1 |
| Okusaka, T | 1 |
| Kosuge, T | 1 |
| Shibata, T | 1 |
| Ho, HK | 1 |
| Pok, S | 1 |
| Streit, S | 1 |
| Ruhe, JE | 1 |
| Hart, S | 1 |
| Lim, KS | 1 |
| Loo, HL | 1 |
| Aung, MO | 1 |
| Lim, SG | 1 |
| Ullrich, A | 1 |
3 other studies available for pd 173074 and Liver Neoplasms
| Article | Year |
|---|---|
PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells.
Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferatio | 2020 |
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Topics: Adenosylhomocysteinase; Aged; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hep | 2014 |
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Case-Control Studie | 2009 |